FDA

Nanomedicines based on poly(lactic-co-glycolic acid) (PLGA) carriers offer tremendous opportunities for biomedical research. Although several PLGA-based systems have already been approved...

The year 2020 was an eventful year for the pharmaceutical industry, with several companies across the world working at a...

On the 14th of November is the annual World Diabetes Day. The 2024 - 2026 theme is "Diabetes and Well-being"....

In its continuous endeavor to bolster the competitiveness of the generics market, the US Food and Drug Administration (FDA) updated...

In case you thought Covid-19 had slowed down the speed at which generic active pharmaceutical ingredient (API) manufacturers were submitting...

High numbers of drug recalls persist despite the tremendous time and effort invested by pharmaceutical organizations and regulatory bodies such...

Do you want to use the USP Pending Monograph process? Or have you ever wondered what the USP Pending Monograph...

Statement from Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn M.D. at March 05, 2020...

The United States Pharmacopeia (USP) appreciates the opportunity to provide comments on a potential FDA novel excipient review program. USP...

  Innovation drives progress in the development of new drugs and therapeutic biological products. 48 new drugs and biological products...